Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
10.99
+0.35 (3.29%)
At close: May 12, 2025, 4:00 PM
10.99
0.00 (0.00%)
After-hours: May 12, 2025, 6:05 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.84 billion as of May 12, 2025. Its market cap has decreased by -10.72% in one year.
Market Cap
7.84B
Enterprise Value
2.80B
1-Year Change
-10.72%
Ranking
Category
Stock Price
$10.99
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.84B, an increase of 1,370.24%. That is a compound annual growth rate of 83.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 7.59B | -11.84% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |